NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma

TerminatedPhase 1

Sponsor: Pfizer

Conditions: Asthma

Interventions: Zavegepant, Placebo

Countries: Canada

This study is a double-blind, parallel-group, randomized study of active drug vs placebo in asthma.

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Subjects with Asthma

Exclusion Criteria:

\-

Locations (10)